232 related articles for article (PubMed ID: 35504983)
1. New insights into the molecular mechanisms of ROR1, ROR2, and PTK7 signaling from the proteomics and pharmacological modulation of ROR1 interactome.
Raivola J; Dini A; Salokas K; Karvonen H; Niininen W; Piki E; Varjosalo M; Ungureanu D
Cell Mol Life Sci; 2022 May; 79(5):276. PubMed ID: 35504983
[TBL] [Abstract][Full Text] [Related]
2. Ror family receptor tyrosine kinases regulate the maintenance of neural progenitor cells in the developing neocortex.
Endo M; Doi R; Nishita M; Minami Y
J Cell Sci; 2012 Apr; 125(Pt 8):2017-29. PubMed ID: 22328498
[TBL] [Abstract][Full Text] [Related]
3. The PTK7 and ROR2 Protein Receptors Interact in the Vertebrate WNT/Planar Cell Polarity (PCP) Pathway.
Martinez S; Scerbo P; Giordano M; Daulat AM; Lhoumeau AC; Thomé V; Kodjabachian L; Borg JP
J Biol Chem; 2015 Dec; 290(51):30562-72. PubMed ID: 26499793
[TBL] [Abstract][Full Text] [Related]
4. Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation.
Yu J; Chen L; Cui B; Widhopf GF; Shen Z; Wu R; Zhang L; Zhang S; Briggs SP; Kipps TJ
J Clin Invest; 2016 Feb; 126(2):585-98. PubMed ID: 26690702
[TBL] [Abstract][Full Text] [Related]
5. A PTK7/Ror2 Co-Receptor Complex Affects Xenopus Neural Crest Migration.
Podleschny M; Grund A; Berger H; Rollwitz E; Borchers A
PLoS One; 2015; 10(12):e0145169. PubMed ID: 26680417
[TBL] [Abstract][Full Text] [Related]
6. Structural Insights into Pseudokinase Domains of Receptor Tyrosine Kinases.
Sheetz JB; Mathea S; Karvonen H; Malhotra K; Chatterjee D; Niininen W; Perttilä R; Preuss F; Suresh K; Stayrook SE; Tsutsui Y; Radhakrishnan R; Ungureanu D; Knapp S; Lemmon MA
Mol Cell; 2020 Aug; 79(3):390-405.e7. PubMed ID: 32619402
[TBL] [Abstract][Full Text] [Related]
7. ROR1 and ROR2 play distinct and opposing roles in endometrial cancer.
Henry CE; Llamosas E; Daniels B; Coopes A; Tang K; Ford CE
Gynecol Oncol; 2018 Mar; 148(3):576-584. PubMed ID: 29395309
[TBL] [Abstract][Full Text] [Related]
8. Evolutionary divergence in the catalytic activity of the CAM-1, ROR1 and ROR2 kinase domains.
Bainbridge TW; DeAlmeida VI; Izrael-Tomasevic A; Chalouni C; Pan B; Goldsmith J; Schoen AP; Quiñones GA; Kelly R; Lill JR; Sandoval W; Costa M; Polakis P; Arnott D; Rubinfeld B; Ernst JA
PLoS One; 2014; 9(7):e102695. PubMed ID: 25029443
[TBL] [Abstract][Full Text] [Related]
9. Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.
Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R; Heinzelmann-Schwarz V; Ford C
Oncotarget; 2015 Nov; 6(37):40310-26. PubMed ID: 26515598
[TBL] [Abstract][Full Text] [Related]
10. Essential role of Wnt5a-Ror1/Ror2 signaling in metanephric mesenchyme and ureteric bud formation.
Qi X; Okinaka Y; Nishita M; Minami Y
Genes Cells; 2016 Apr; 21(4):325-34. PubMed ID: 26840931
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of rat Ror1 and Ror2 genes in silico.
Katoh M; Katoh M
Int J Mol Med; 2005 Mar; 15(3):533-8. PubMed ID: 15702250
[TBL] [Abstract][Full Text] [Related]
12. The Ror1 receptor tyrosine kinase plays a critical role in regulating satellite cell proliferation during regeneration of injured muscle.
Kamizaki K; Doi R; Hayashi M; Saji T; Kanagawa M; Toda T; Fukada SI; Ho HH; Greenberg ME; Endo M; Minami Y
J Biol Chem; 2017 Sep; 292(38):15939-15951. PubMed ID: 28790171
[TBL] [Abstract][Full Text] [Related]
13. Role of the Ror family receptors in Wnt5a signaling.
Kamizaki K; Minami Y; Nishita M
In Vitro Cell Dev Biol Anim; 2024 Apr; ():. PubMed ID: 38587578
[TBL] [Abstract][Full Text] [Related]
14. Comparative genomics on ROR1 and ROR2 orthologs.
Katoh M; Katoh M
Oncol Rep; 2005 Nov; 14(5):1381-4. PubMed ID: 16211313
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2.
O'Connell MP; Marchbank K; Webster MR; Valiga AA; Kaur A; Vultur A; Li L; Herlyn M; Villanueva J; Liu Q; Yin X; Widura S; Nelson J; Ruiz N; Camilli TC; Indig FE; Flaherty KT; Wargo JA; Frederick DT; Cooper ZA; Nair S; Amaravadi RK; Schuchter LM; Karakousis GC; Xu W; Xu X; Weeraratna AT
Cancer Discov; 2013 Dec; 3(12):1378-93. PubMed ID: 24104062
[TBL] [Abstract][Full Text] [Related]
16. Cellular and molecular mechanisms implicated in the dual role of ROR2 in cancer.
Castro MV; Lopez-Bergami P
Crit Rev Oncol Hematol; 2022 Feb; 170():103595. PubMed ID: 35032666
[TBL] [Abstract][Full Text] [Related]
17. Cellular thermal shift assay (CETSA) for determining the drug binding affinity using Ba/F3 clones stably expressing receptor pseudokinases.
Karvonen H; Raivola J; Ungureanu D
Methods Enzymol; 2022; 667():339-363. PubMed ID: 35525546
[TBL] [Abstract][Full Text] [Related]
18. Targeting ROR1 identifies new treatment strategies in hematological cancers.
Karvonen H; Niininen W; Murumägi A; Ungureanu D
Biochem Soc Trans; 2017 Apr; 45(2):457-464. PubMed ID: 28408486
[TBL] [Abstract][Full Text] [Related]
19. ROR1 and ROR2 expression in pancreatic cancer.
Liu D; Sharbeen G; Phillips P; ; Ford CE
BMC Cancer; 2021 Nov; 21(1):1199. PubMed ID: 34763666
[TBL] [Abstract][Full Text] [Related]
20. Wnt5a induces ROR1 and ROR2 to activate RhoA in esophageal squamous cell carcinoma cells.
Wu X; Yan T; Hao L; Zhu Y
Cancer Manag Res; 2019; 11():2803-2815. PubMed ID: 31114334
[No Abstract] [Full Text] [Related]
[Next] [New Search]
